Endocannabinoid and cannabinoid receptor expression levels within tissues shift in many pathological states, underlying the pro-homeostatic role of the endocannabinoid system in inflammation. The on-demand production and metabolism of endocannabinoids underscores their role in the body’s rapid response to injury or disease. In some pathologies such as diabetes, endocannabinoids can actually have a pro-inflammatory effect, and interventions are required to restore endocannabinoid tone to normal levels to protect insulin-producing cells in the pancreas. Developing products that address pathological endocannabinoid dysregulation and inflammatory response in the nervous system and throughout the body is a key goal for Phytecs.


The endocannabinoid system balances the performance of many physiological processes within the body. This is best illustrated by the role of the endocannabinoid system in inflammatory conditions. Endocannabinoids can support inflammation or suppress it. These compounds function as a key modulator of both immunity and inflammation. From dermatitis to cancer, Phytecs is researching and developing products that help the body fight disease and dysfunction through properly controlling endocannabinoid function.


Many of the most pressing health issues are connected to dysfunction of the endocannabinoid system. Lawmakers and public officials need to stay abreast of the latest research conducted by Phytecs, since the impact of this research is far-reaching. As the societal burden and costs associated with metabolic disorders such as obesity and diabetes explode, government must encourage the kinds of solutions and innovations that Phytecs develops.


The critical role played by the endocannabinoid system in regulating immune response and inflammation creates a plethora of opportunities for strategic partnerships between Phytecs and innovative companies. Phytecs researchers are currently developing proprietary compounds that will create the therapies of tomorrow for widespread metabolic disorders such as obesity, diabetes and mental illness.

Creative Commons License
ECS Inflammation by Artwork by John Karapelou, Text by Phytecs is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License